TAKE ON PH1 Trademark Information

Trademark by Alnylam Pharmaceuticals, Inc.

Promoting public awareness about primary hyperoxaluria among affected individuals and their families

Educational services, namely, providing education information for training medical professionals and patients regarding primary hyperoxaluria

Providing medical information about primary hyperoxaluria

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (035)
Advertising; business management; business administration; office functions.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (041)
Education; providing of training; entertainment; sporting and cultural activities.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: TAKE ON PH1
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
6/15/2021
Serial Number: 88803039
Filing Date: 2/19/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Promoting public awareness about primary hyperoxaluria among affected individuals and their families
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Alnylam Pharmaceuticals, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
6/15/2021
Correspondent Search:
ANN LAMPORT HAMMITTE is a correspondent of TAKE ON PH1 trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on